Skip to search formSkip to main contentSkip to account menu

Tarafenacin

Known as: (3R)-1-Azabicyclo(2.2.2)Octan-3-Yl (3-Fluorophenyl)((3,4,5-Trifluorophenyl)Methyl)Carbamate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomized, double- blind, placebo-controlled phase 2 study
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)